Current through Register Vol. 42, No. 5, February 29, 2024
(1) A Processor must properly package its
approved medical cannabis products as follows:
(a) Packaging and containers must be
child-resistant.
(b) Packaging and
containers must be tamper-evident.
(c) Packaging and containers (or labels, see
below) must identify the Processor and type of product.
(d) Packaging and containers must not be
attractive to minors.
(e) Packaging
and containers must be designed to minimize appeal to children.
(f) Packaging and containers must not contain
any false statement or statement that advertises health benefits or therapeutic
benefits of medical cannabis.
(2) A Processor must properly label its
packages of medical cannabis as follows:
(a)
Labels must be securely attached to or imprinted on the accompanying
packaging.
(b) Labels must be clear
and contain print of a size and quality so as to be legible to the average
patient or caregiver with a sixth-grade education.
(c) Labels must identify the type of product
(pills, tinctures, transdermal patches, etc.).
(d) Labels must contain lot and batch
numbers.
(e) Labels must contain
the name of and a license identification number for the Cultivator.
(f) Labels must contain the name of and a
license identification number for the Processor.
(g) Labels must identify the cannabinoid
content and potency of the product.
(h) Labels must identify the amount, number
or count of the product in the package on which they are attached.
(i) Labels must contain the universal state
symbol approved by the Commission, printed in color at least one-half inch by
one-half inch in size.
(j) Labels
must contain the words "Keep out of reach of children."
(k) Labels must contain a digital image or QR
Code for purposes of tracking medical cannabis products and must interface with
the Statewide Seed-to-Sale Tracking System.
(l) Labels, or if space is not available, a
package insert, must contain the following: "WARNING:
This product may make you drowsy or dizzy. Do not drink alcohol
with this product. Use care when operating a vehicle or other machinery. Taking
this product with medication may lead to harmful side effects or complications.
Consult your physician before taking this product with any medication. Women
who are breastfeeding, pregnant, or plan to become pregnant should discuss
medical cannabis use with their physicians."
(m) Labels must not be attractive to
minors.
(n) Labels must not contain
any false statement or statement that advertises health benefits or therapeutic
benefits of medical cannabis.
(o)
At the time of labeling, Processors must provide QR Coding or other approved
digital coding to identify, at a minimum, the following:
1. The Cultivator or Integrated Facility, by
facility, from which the medical cannabis was sourced,
2. The name of the Processor and the
Processor's facility of origin,
3.
The type of product,
4. The date of
processing and packaging,
5. The
date of the Processor's State Testing Laboratory approval,
6. The expiration date (or, if no expiration
date, a notation that the expiration date does not apply), and
7. The Alabama Poison Control contact
information as provided on the AMCC website.
